Jonathan R Strosberg (Jonathan Strosberg)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Peritoneal Dialysis

Ejection Fraction

Top Venues

Journal of neuroendocrinology

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr, Sydney Pulsipher, Fang-Shu Ou, Amylou C Dueck, Jared Acoba, Ardaman Shergill, Edward M Wolin, Thorvardur R Halfdanarson, Bhavana Konda, Nikolaos A Trikalinos, Bernard Tawfik, Nitya Raj, Shagufta Shaheen, Namrata Vijayvergia, Arvind Dasari, Jonathan R Strosberg, Elise C Kohn, Matthew H Kulke, Eileen M O'Reilly, Jeffrey A Meyerhardt
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. The New England journal of medicine (2024)
Adam Alayli, Hoang Ngo, Dhiraj Sikaria, Altan Ahmed, Elias Salloum, Jonathan R Strosberg, Taymeyah E Al-Toubah, Bela Kis, Mintallah Haider, Ghassan El-Haddad
Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors. Cancers 16 (15) (2024)
Dae Won Kim, Young-Chul Kim, Bence P Kovari, Maria Martinez, Ruoyu Miao, James Yu, Rutika Mehta, Jonathan R Strosberg, Iman Imanirad, Richard D Kim
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. Cancers 16 (3) (2024)
Adam Alayli, Hoang Ngo, Dhiraj Sikaria, Altan Ahmed, Elias Salloum, Jonathan R Strosberg, Taymeyah E Al-Toubah, Bela Kis, Mintallah Haider, Ghassan El-Haddad
Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors. Cancers 16 (15) (2024)
Jonathan R Strosberg, Taymeyah Al-Toubah
Surgical management of metastatic neuroendocrine tumors: beyond the realm of evidence-based medicine. Hepatobiliary surgery and nutrition 13 (3) (2024)
Jonathan R Strosberg, Taymeyah Al-Toubah
Surgical management of metastatic neuroendocrine tumors: beyond the realm of evidence-based medicine. Hepatobiliary surgery and nutrition 13 (3) (2024)
Dae Won Kim, Young-Chul Kim, Bence P Kovari, Maria Martinez, Ruoyu Miao, James Yu, Rutika Mehta, Jonathan R Strosberg, Iman Imanirad, Richard D Kim
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. Cancers 16 (3) (2024)
Halfdan Sorbye, Grace Kong, Simona Grozinsky-Glasberg, Jonathan R Strosberg
PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). Journal of neuroendocrinology (2024)
Jaydira Del Rivero, Kimberley J Perez, Erin B Kennedy, Erik S Mittra, Namrata Vijayvergia, Junaid Arshad, Sandip Basu, Aman Chauhan, Arvind N Dasari, Andrew M Bellizzi, Alexandra Gangi, Erin Grady, James R Howe, Jana Ivanidze, Mark Lewis, Josh Mailman, Nitya Raj, Heloisa P Soares, Michael C Soulen, Sarah B White, Jennifer A Chan, Pamela L Kunz, Simron Singh, Thorvardur R Halfdanarson, Jonathan R Strosberg, Emily K Bergsland
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sonia M Abuzakhm, Vineeth K Sukrithan, Briant Fruth, Rui Qin, Jonathan R Strosberg, Timothy J Hobday, Thomas Semrad, Diane Reidy-Lagunes, Hedy Lee Kindler, George P Kim, Jennifer J Knox, Andreas Kaubisch, Miguel Villalona-Calero, Helen Chen, Charles Erlichman, Manisha H Shah
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocrine-related cancer 30 (11) (2023)
Taymeyah E Al-Toubah, Eleonora Pelle, Julie Hallanger-Johnson, Mintallah Haider, Jonathan R Strosberg
ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series. Journal of neuroendocrinology (2023)
Rohit Gosain, Medhavi Gupta, Arya Mariam Roy, Jonathan R Strosberg, Kathryn M Glaser, Renuka Iyer
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review. Cancers 14 (6) (2022)
Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher, Teri A Longacre, Carlos J Suarez, Brock A Martin, James C Yao, Matthew H Kulke, Andrew E Hendifar, James C Shanks, Manisha H Shah, Mark M Zalupski, Edmond L Schmulbach, Diane L Reidy, Jonathan R Strosberg, Peter J O'Dwyer, Al Bowen Benson
A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Kathryn DeCarli, Jonathan R Strosberg, Khaldoun Almhanna
Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update. Cancers 14 (17) (2022)
Aileen Xu, Pilar Suz, Tea Reljic, Abhirup C Are, Ambuj Kumar, Benjamin Powers, Jonathan R Strosberg, Jason W Denbo, Jason B Fleming, Daniel A Anaya
Perioperative Carcinoid Crisis: A Systematic Review and Meta-Analysis. Cancers 14 (12) (2022)
Taymeyah E Al-Toubah, Brian Morse, Jonathan R Strosberg
Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors. Current oncology (Toronto, Ont.) 29 (2) (2022)
Mintallah Haider, Douglas B Johnson, Taymeyah Al-Toubah, Eleonora Pelle, Ghassan El-Haddad, Jonathan R Strosberg
Somatostatin receptor radionuclide therapy in neuroendocrine tumors. Endocrine-related cancer 28 (3) (2022)
Jonathan R Strosberg, Ken Herrmann, Lisa Bodei
The Future of Targeted Alpha Therapy is Bright but Rigorous Studies are Necessary to Advance the Field. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Jonathan R Strosberg, Ghassan El-Haddad, Taymeyah Al-Toubah, Diane L Reidy, Etay Ziv, Armeen Mahvash, Arvind Dasari, Philip Philip, Michael C Soulen
Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is it an Either/Or Question? Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Cathy Eng, Emerson Y Chen, Jane E Rogers, Mark A Lewis, Jonathan R Strosberg, Ramya Thota, Smitha Krishnamurthi, Paul E Oberstein, Rang Govindarajan, Gary Buchschacher, Sandip Patel, Davendra Sohal, Taymeyah E Al-Toubah, Philip Philip, Arvind N Dasari, Hagen F Kennecke, Stacey Stein
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. JCO oncology practice 17 (10) (2021)
Satya Das, Taymeyah E Al-Toubah, Jonathan R Strosberg
Chemotherapy in Neuroendocrine Tumors. Cancers 13 (19) (2021)
Taymeyah Al-Toubah, Simona Grozinsky-Glasberg, Jonathan R Strosberg
An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Current treatment options in oncology 22 (4) (2021)
Eleonora Pelle, Taymeyah E Al-Toubah, Brian Morse, Ghassan El-Haddad, Jonathan R Strosberg
Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy. Journal of neuroendocrinology 33 (2) (2021)
Jonathan R Strosberg, Pamela L Kunz, Andrew Hendifar, James Yao, David Bushnell, Matthew H Kulke, Richard P Baum, Martyn Caplin, Philippe Ruszniewski, Ebrahim Delpassand, Timothy Hobday, Chris Verslype, Al Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaume Mora, Jordan Berlin, Enrique Grande, Nicholas Reed, Ettore Seregni, Giovanni Paganelli, Stefano Severi, Michael Morse, David C Metz, Catherine Ansquer, Frédéric Courbon, Adil Al-Nahhas, Eric Baudin, Francesco Giammarile, David Taïeb, Erik Mittra, Edward Wolin, Thomas M O'Dorisio, Rachida Lebtahi, Christophe M Deroose, Chiara M Grana, Lisa Bodei, Kjell Öberg, Berna Degirmenci Polack, Beilei He, Maurizio F Mariani, Germo Gericke, Paola Santoro, Jack L Erion, Laura Ravasi, Eric Krenning, null null
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study. European journal of nuclear medicine and molecular imaging 47 (10) (2020)
Nikhil Chauhan, Mary F Mulcahy, Riad Salem, Al Bowen Benson, Eveline Boucher, Janet Bukovcan, David Cosgrove, Chantal Laframboise, Robert J Lewandowski, Fayaz Master, Bassel F El-Rayes, Jonathan R Strosberg, Daniel Y Sze, Ricky A Sharma
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial. JMIR research protocols 8 (1) (2019)
Taymeyah E Al-Toubah, Brian Morse, Jonathan R Strosberg
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms. The oncologist 25 (1) (2019)